› Forums › General Melanoma Community › New PD-L1 inhibitors
- This topic has 3 replies, 1 voice, and was last updated 9 years ago by
Bubbles.
- Post
-
- May 19, 2016 at 5:32 pm
Hey folks,
These are being tested in other cancers, but I wonder if they will come to have relevance for the melanoma community?
I thought some of you might be interested-
John
In the 61-patient study, about 30 percent of those with Merkel skin cell carcinoma treated with Merck's avelumab saw their tumors shrink or disappear.
Avelumab, which German Merck is developing with Pfizer Inc , belongs to a class of drugs called PD-L1 inhibitors that block a mechanism tumors use to hide from the immune system, allowing it to recognize and attack the cancer. They are closely related to the PD-1 drugs already on the market from Bristol-Myers Squibb (Opdivo) and Merck & Co (Keytruda) seen as major advances against melanoma, lung cancer and other malignancies.
Roche's Tecentriq earlier on Wednesday became the first approved PD-L1 drug, gaining U.S. approval to treat advanced bladder cancer.
- Replies
-
-
- May 19, 2016 at 11:47 pm
Yes, it's pretty cool stuff! I posted this today….which also includes data from Tecentriq trial in melanoma that Weber mentioned in his 2016 webinar re immunotherapy: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2016/05/atezolizumab-renamed-tecentriq-fda.html
Thanks for sharing! Celeste
-
- May 19, 2016 at 11:47 pm
Yes, it's pretty cool stuff! I posted this today….which also includes data from Tecentriq trial in melanoma that Weber mentioned in his 2016 webinar re immunotherapy: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2016/05/atezolizumab-renamed-tecentriq-fda.html
Thanks for sharing! Celeste
-
- May 19, 2016 at 11:47 pm
Yes, it's pretty cool stuff! I posted this today….which also includes data from Tecentriq trial in melanoma that Weber mentioned in his 2016 webinar re immunotherapy: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2016/05/atezolizumab-renamed-tecentriq-fda.html
Thanks for sharing! Celeste
-
Tagged: cutaneous melanoma
- You must be logged in to reply to this topic.